Professor Paul J Smith received his BSc in Medical Microbiology from the University of Bristol (UK) in 1974 and received his PhD in 1977 from the University of Manchester (UK) for studies on cellular radiobiology at the Paterson Institute, Manchester. He has been active in the field of cellular responses to DNA damage for over 20 years.

Between 1977 and 1979 he was a NERC (Canada) Research Fellow in the Biology Branch of Chalk River Nuclear Laboratories (CRNL) Canada and later as a research scientist funded by the US National Cancer Institute investigating DNA repair in persons genetically predisposed to cancer. In 1982 he joined the Medical Research Council Centre (Cambridge, UK) and as a senior scientist led a programme directed towards the identification of factors controlling cellular sensitivity to DNA damage. In 1995 he was appointed to the new Chair of Cancer Biology at the University of Wales College of Medicine. Now retired he is Emeritus Professor of Cancer Biology. He is also a past President of the International Society for Analytical Cytology (ISAC).

In 2000, he co-founded BioStatus and sits on the board as a Non-Executive Director. He is also CSO of OncoTherics and Science Director of both BioSuspensions and BioTherics.

In addition, Paul is extremely well known on the international research circuit and is highly respected by key opinion leaders all over the world.